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ABSTRACT
The complexity depicted by disease scenarios as diabetes mellitus, constitutes a very interesting field of study when drugs and biologically relevant components may be affected by such environments. In this report, the interaction between the protein Human Serum Albumin (HSA) and two antidiabetics (Andb), Gliclazide (Gli) and Glipizide (Glip) was studied through fluorescence and docking assays, in order to characterize these systems. On the basis that HSA and Andb can be exposed in vivo at high Reactive Oxygen Species (ROS) concentrations in diabetic patients, the degradative process of the protein free and bound to Andb, in presence of the species singlet molecular 
INTRODUCTION
Protein binding describes the ability of biomolecules to interact with other species through reversible or irreversible processes. In fact, the biological properties of a protein are highly dependent on its binding abilities. In this sense, enzymatic action, hormone activity and genic regulation are some examples of important biological processes wherein protein binding plays very important roles [1] . Drug transport is another example of such processes, in which the binding of drugs to serum proteins has an important effect on their distribution and therapeutic action, since only free drugs are able to interact with their specific receptor [2] .
In humans, the most abundant of serum proteins is Human Serum Albumin (HSA) and its main function is the transport of compounds. Besides, this protein presents enzymatic activities as well as important antioxidant functions in blood serum [3] . Thus, HSA is a multifunctional protein, and most of its properties are principally derived from its ligand-binding abilities. In this context, it is well known that under disease scenarios such as cancer, diabetes mellitus, and liver o renal pathology, these protein binding properties can be seriously altered [2] .
Particularly, diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action or both [4] . The characteristic high blood glucose concentrations associated with this disease generate a cascade of processes which may affect, among many other, protein binding functions [5] . Diabetes mellitus is a world widely disseminated disease that has increased very fast along the last years.
In fact, around 8 % of the total world population suffers this disease and it is 6 estimated that the number of patients will rise even more in future years [4] . The vast majority of cases of diabetes fall into two broad ethiopatogenic categories: diabetes mellitus type I, and the more prevalent diabetes mellitus type II (around 80% of the patients). At present, the treatment for diabetes type II includes the use of the second-generation sulfonylurea compounds such as Gliclazide, Glipizide, Glibenclamide and Glimepiride. These antidiabetics (Andb), considered as weak acidic compounds, act by stimulating insulin secretion from beta cells in pancreas and could bind HSA since it is well known that acidic and neutral compounds tend to bind albumin [6, 7] .
On the other hand, it is well established that elevated sugar levels in diabetic patients is associated with increased Reactive Oxygen Species (ROS) intracellular production, which generates an oxidative stressing environment [8] .
In parallel, previous reports demonstrate that oxidative damage plays an important role in diabetes genesis and its complications [5, [9] [10] [11] .
In this context, since Andb and HSA may be exposed to oxidative stress in common microenvironments, the study of the potential effect of ROS on the free and bonded species constitutes an approach of highly practical interest.
In the present contribution, the binding parameters between HSA and Andb were determined through fluorescence measurements and supported with docking assays. Furthermore, the oxidability of free and bonded entities was evaluated employing photogenerated singlet molecular oxygen (O 2 ( 1 ∆ g )) as an archetypal oxidative species in a potential oxidative stressing scenery. 7 
MATERIALS AND METHODS

Materials
Gliclazide (Gli), Glipizide (Glip), Human Serum Albumin (HSA; fatty acid free), Perinaphtenone (PN), deuterated water (99.9 %) and NaOH were obtained from Sigma-Aldrich Argentina S.A. KH 2 PO 4 and methanol (HPLC quality) were obtained from Cicarelli and Sintorgan, respectively.
Due to low Andb solubility in aqueous solutions, the experiments were made using methanol as a co-solvent (10%) and 0.1 M phosphate buffer (pH 7.4). The presence of this percentage of methanol does not produce changes in HSA properties [12] . HSA solutions were prepared, based on a molecular weight of 66500Da [13] .
Methods
Determination of binding parameters
HSA is a single chain protein that contains one tryptophan residue (Trp214). Since the emission of this aminoacid is very sensitive to changes in its microenvironment, its fluorescence can be used as a signal for monitoring interactions [14] . So, in binding assays the fluorescence intensities of HSA were determined by monitoring the changes in fluorescence intensities from Trp214.
The binding parameters, association constant (K bi ) and total number of binding sites (n), were determined from fluorescence experimental data, using a model of binding isotherm based on the following equation [15] .
(1) Fluorescence emission spectra were measured by using Spex Fluoromax equipment. Quartz cuvettes of 1.0 cm of path length were used.
Samples were excited at 295 nm and the fluorescence emission was recorded at 340 nm.
The absorption spectra were measured employing Hewlett Packard 8452A diode array spectrophotometer.
On the other hand, thermodynamic parameters for HSA-Andb interaction were determined from binding experiments carried out at four temperatures.
Considering that enthalpy change (∆H 
Docking assays
The docking studies were carried out as previously described [19] .
Briefly, ICM version 3.4 was used and the icmPocketFinder function was employed to detect possible binding sites with a tolerance of 4.6 by default [20] .
This parameter is related to flexibility for sites prediction. The lower the tolerance value the more pockets predicted and the higher the tolerance the were carried out in a home-made photolyser [23] . It is provided with a quartzhalogen lamp (OSRAM XENOPHOT HPLX 64640, 150w-24 V G35, OSRAM Augsburg, Germany). The light was passed through a water filter and focused on a hermetically sealed reaction cell with a specific oxygen electrode (Orion 97-08). The solutions were continuously stirred. Light at λ< 320 nm was filtered using a cut-off filter in order to ensure that the light was only absorbed by the sensitizer. PN has a quantum yield of O 2 ( 1 ∆ g ) generation close to unity. This quantum yield remains independent of solvent and this is the reason why PN may be established as a universal O 2 ( 1 ∆ g ) reference sensitizer [24] .
From oxygen uptake, the initial slopes were determined in order to evaluate the rates of oxygen consumption by HSA, Andb and HSA-Andb.
The laser-kinetic spectrophotometer for time resolved phosphorescence detection of O 2 ( 1 ∆ g ) (TRPD) has been previously described [25] . Briefly, it ) quenching, k t (addition k q + k r , processes [4] and [5] , respectively, in Scheme 1) were determined through Stern-Volmer treatment: (7) where [A] = molar concentration of Andb and/or HSA.
RESULTS AND DISCUSSION
The structures of Gli and Glip are shown in Fig. 1 . pK a values for Gli and Glip are 5.8 and 6.2, respectively [27] . Thus, both drugs may exist as ionized species under the experimental conditions (pH 7.4). this sense, the binding constants were evaluated and the number and identification of binding sites were determined.
Binding parameters
Solutions containing HSA (1x10 Glip indicated that the best binding isotherm fit was obtained when n=2 (Fig. 2 ).
This means that both Andb could bind HSA in two sites. Thus, the correspondent binding constants K bi and K bii were determined from the fitting of the binding isotherm (Eq. 1). The binding constants were determined at different temperatures in order to investigate the potential dependence between both variables (Eq. 5). Results are shown in Table 2 . Waals or hydrogen bonding interactions [30] . In this sense, Glip is one of the sulfonylureas possessing higher hydrogen-bonding capacity (9 proton acceptor groups and 3 proton donor groups) and therefore hydrogen bonding may be the interactions involved in the HSA-Glip association process [27] .
On the other hand, it can be suggested that net positive ∆S 0 values may be due to energetic contribution of the hydrophobic association, related to the first step that involves a reorganization of the solvent structure around the protein and the ligand [30] . The ∆S 0 sign could be explained in terms of a great disorder in the solvent structure around the protein-ligand complex as compared to the isolated hydrated species.
Regarding the binding parameters, it is important to notice that from the analysis of fluorescence data and the subsequent fit of binding isotherms, it is only possible to estimate the number of binding sites and to calculate the binding constants. However, it is not possible to assign each binding constant to a particular site. In order to support the experimental data based on the number of sites of interaction between HSA and Andb and to suggest the possible location of these sites, docking experiments were performed in this study.
Docking assays
The 
Docking in binding site I
18
The binding site I is located in subdomain IIA (Fig. 3) , and it is formed by residues Tyr150, Glu153, Phe157, Glu188, Ala191, Ser192, Lys195, Gln196, Lys199, Phe211, Trp214, Ala215, Arg218, Leu219, Arg222, Phe223, Leu238, His242, Arg257, Leu260, Ala261, Ile264, Ser287, His288, Ile290, Ala291 and Glu292. The entrance to the pocket is formed by charged residues and the core, by hydrophobic side chains. Docking with ligands, Gli and Glip, while mapping this pocket resulted in conformations located outside the pocket in the cleft between domains I and III, and since the location was mostly in a region of solvent accessibility, the possibility of binding in this region was discarded.
Docking in binding site II
This binding site is located in subdomain IIIA (Fig. 3) , which is smaller than site I and is formed by residues Leu387, Ile388, Gln390, Asn391, Phe403, 
Docking in binding site III
The binding site III is located in the subdomain IB and in the interphase with subdomain IIIA (Fig. 3) and is constituted by residues Asp108, Asn109, 20 Pro110, Leu112, Leu115, Val116, Arg117, Pro118, Met123, Phe134, Lys137, Tyr138, Glu141, Ile142, Arg145, His146, Pro147, Tyr148, Phe149, Tyr161, Leu182, Leu185, Arg186, Asp187, Gly189, Lys190, Ala191, Ser193, Ala194, Arg197, Glu425, Asn429, Lys432, Tyr452, Val456, Gln459, Val462 and Leu463.
It is a very bulky pocket formed mainly by positively charged and hydrophobic residues. Docking mapping this site resulted in two major conformations for both ligands (Fig. 5 and 6 ). These results are in agreement with previous reports since several drugs were reported as having the capacity to bind to more than one site in HSA, for example, indomethacine and azapropazone bind to binding sites I and III and ibuprofen binds to sites I and II [31] .
On the other hand, conventional binding studies between several compounds and HSA have postulated the sites I and II as the only probably binding sites [32] [33] [34] . In the last decade, docking assays have demonstrated that there are other cavities distributed across the protein that act as alternative binding sites. Site III has been described as a preferred site for several drugs in other docking studies [35] . These authors suggest that the steric factor seems to play the most important role in the transportation of drugs by HSA. The results presented in this section were interpreted and discussed following the processes shown in the next scheme. Photoirradiation at λ>320 nm of the system PN/Andb and/or HSA/ oxygen produced modifications in the absorption spectra of photooxidizable substrates, indicating chemical changes in the compounds. In parallel, oxygen uptake was observed (Fig. 7) . From oxygen consumption plots, initial rates were determined as shown in Table 3 , where they are expressed as relative oxygen uptake rates (v r ). As can be seen in Gli and Glip bind in site II and site III and that several tyrosine residues are involved in these binding sites. In Fig. 4 , the participation of Tyr411 in binding site II can be noticed. Likewise, when Gli binds to site III, the residue Tyr452 is involved in one conformation (Fig. 5A) , and the residue Tyr138, in the other conformation (Fig. 5B ). In the case of Glip, bound in site III, the participation of the residues Tyr161 and Tyr138 in both conformations can be seen ( Fig. 6A and 6B). Therefore, the decrease observed in k t values when the Andb are bound to the protein, compared to k t value for HSA free, may be attributed to 
